Prescribing information and Adverse event reporting can be found at the bottom of the page
Brand Navigation Banner
Search Header
Not currently promoted but still available.
Jaydess®▼ (13.5mg intrauterine delivery system levonorgestrel) is an IUS indicated for contraception for up to 3 years.
Kyleena (levonorgestrel 19.5mg intrauterine delivery system) prescribing information
Have you thought about Kyleena?
Kyleena®: smallest T-body and narrowest insertion tube available in a 5-year IUS1
Same size T-body frame as Jaydess2,3
- Placement of Kyleena® is considered easy by healthcare professionals in 90% (n=1452) of women, regardless of parity.1
- Women rated the pain of placement as ‘none’ or mild’ in 65% (n=1452) of cases.1
Open-label extended trial involving 1453 women to evaluate efficacy, safety, tolerability of Kyleena for up to 5 years of use1
- Nelson AL, et al. Expert Rev Clin Pharmacol, 2017;10(8):833–842. Return to content
- Bayer Plc. Kyleena® 19.5mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated December 2021. Available from: https://www.medicines.org.uk/emc/product/769/smpc [Last accessed: January 2022]. Return to content
- Bayer Plc. Jaydess®▼ 13.5mg intrauterine delivery system (levonorgestrel): Summary of Product Characteristics [online]. Updated December 2021. Available from: https://www.medicines.org.uk/emc/product/5297/smpc [Last accessed: January 2022]. Return to content
Latest content
PP-PF-WHC-GB-1004 May 2022
Reporting adverse events and quality complaints
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.
If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: pvuk@bayer.com
Further information is available on the “contact” tab at www.bayer.co.uk.
